Relationship of octanoylcarnitine concentrations to age at sampling in unaffected newborns screened for medium-chain acyl-CoA dehydrogenase deficiency

Clinical Chemistry

Volumn 56, Issue 6, 2010, Pages 1015-1021

  Khalid, Javaria M ^a   Oerton, Juliet ^a   Besley, Guy ^b   Dalton, Neil ^c   Downing, Melanie ^d   Green, Anne ^e   Henderson, Mick ^f   Krywawych, Steve ^g   Wiley, Veronica ^h   Wilcken, Bridget ^h   Dezateux, Carol ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

^d SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^e BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^f ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^g GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^h CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARNITINE DERIVATIVE; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; OCTANOYLCARNITINE; UNCLASSIFIED DRUG;

ARTICLE; AUSTRALIA; BIRTH WEIGHT; BLOOD SAMPLING; ENZYME DEFICIENCY; FEMALE; GESTATIONAL AGE; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE DEFICIENCY; NEWBORN; NEWBORN SCREENING; PREMATURITY; QUALITY CONTROL; TANDEM MASS SPECTROMETRY; UNITED KINGDOM; VERY LOW BIRTH WEIGHT;

ACYL-COA DEHYDROGENASE; AGE FACTORS; AMINO ACID METABOLISM, INBORN ERRORS; AUSTRALIA; CARNITINE; ENGLAND; FEMALE; HUMANS; INFANT, NEWBORN; MALE;

EID: 77952993272     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.143891     Document Type: Article

References (20)

1. Chace DH, Hillman SL, Van Hove JL, Naylor EW. Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry. Clin Chem 1997;43:2106-2113
2. Clayton PT, Doig M, Ghafari S, Meaney C, Taylor C, Leonard JV, et al. Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry. Arch Dis Child 1998;79:109-115 (Pubitemid 28384842)
3. Derks TG, Boer TS, van Assen A, Bos T, Ruiter J, Waterham HR, et al. Neonatal screening for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in the Netherlands: the importance of enzyme analysis to ascertain true MCAD deficiency. J Inherit Metab Dis 2008;31:88-96.
4. Carpenter K, Wiley V, Sim KG, Heath D, Wilcken B. Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies. Arch Dis Child Fetal Neonatal Ed 2001;85:F105-9.
5. Wiley V, Carpenter K, Wilcken B. Newborn screening with tandem mass spectrometry: 12 months' experience in NSW Australia. Acta Paediatr Suppl 1999;88:48-51.
6. Millington DS, Kodo N, Norwood DL, Roe CR. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 1990;13:321-324 (Pubitemid 20338872)
7. Zytkovicz TH, Fitzgerald EF, Marsden D, Larson CA, Shih VE, Johnson DM, et al. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem 2001;47:1945-1955 (Pubitemid 33010710)
8. Ades AE, Walker J, Jones R, Smith I. Coverage of neonatal screening: failure of coverage or failure of information system. Arch Dis Child 2001;84: 476-479 (Pubitemid 33027585)
9. Commonwealth of Australia. About Medicare in Australia. 2009. http://www.medicareaustralia. gov.au/about/index.jsp (Accessed December 2009).
10. Green NS, Dolan SM, Murray TH. Newborn screening: complexities in universal genetic testing. Am J Public Health 2006;96:1955-1959 (Pubitemid 44655919)
11. Rhead WJ. Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: a global perspective. J Inherit Metab Dis 2006; 29:370-377 (Pubitemid 43880637)
12. Pourfarzam M, Morris A, Appleton M, Craft A, Bartlett K. Neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency. Lancet 2001; 358:1063-1064 (Pubitemid 32925130)
13. Van Hove JL, Zhang W, Kahler SG, Roe CR, Chen YT, Terada N, et al. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood. Am J Hum Genet 1993;52:958-966 (Pubitemid 23313717)
14. Ziadeh R, Hoffman EP, Finegold DN, Hoop RC, Brackett JC, Strauss AW, et al. Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: neonatal screening shows high incidence and unexpected mutation frequencies. Pediatr Res 1995;37:675-678
15. Blois B, Riddell C, Dooley K, Dyack S. Newborns with C8-acylcarnitine level over the 90th centile have an increased frequency of the common MCAD 985A>G mutation. J Inherit Metab Dis 2005;28:551-556 (Pubitemid 40753683)
16. Department of Human Services, Incorporating: Health, Aged Care, Housing and Community Services. Guidelines for newborn screening: November 2001. http://www.health.vic.gov.au/nbs/ downloads/nbsguidelines.pdf (Accessed April 2010).
17. Grosse SD, Khoury MJ, Greene CL, Crider KS, Pollitt RJ. The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update. Genet Med 2006;8:205-212 (Pubitemid 43756052)
18. Lehotay DC, Lepage J, Thompson JR, Rockman- Greenberg C. Blood acylcarnitine levels in normal newborns and heterozygotes for medium-chain acyl-CoA dehydrogenase deficiency: a relationship between genotype and biochemical phenotype? J Inherit Metab Dis 2004;27:81-88
19. Khalid JM, Oerton J, Cortina-Borja M, Andresen BS, Besley G, Dalton RN, et al. Ethnicity of children with homozygous c. 985A>G medium-chain acyl-CoA dehydrogenase deficiency: findings from screening approximately 1.1 million newborn infants. J Med Screen 2008;15:112-117
20. Griffiths LJ, Tate AR, Dezateux C. Do early infant feeding practices vary by maternal ethnic group? Public Health Nutr 2007;10:957-964